Select Medical (SEM) Stock Price, News & Analysis

Company Overview

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions. In 2013, the company completed the spin-off of its real estate assets into a separate publicly traded real estate investment trust, enabling Select Medical to focus on clinical operations while maintaining long-term facility relationships. Over the years, Select Medical has collaborated with leading health systems and academic medical centers to expand its post-acute care offerings.

Today, Select Medical’s combined network includes more than 130 hospitals and nearly 1,600 outpatient rehabilitation clinics across over 30 states. Its facilities provide specialized services such as ventilator weaning, stroke and neurological recovery, orthopedic and cardiac rehabilitation, and workplace injury recovery. The company’s outpatient clinics serve patients of all ages and conditions with evidence-based therapy programs designed to restore function and promote independence.

Under the leadership of President and CEO J. David Chernow, Select Medical has emphasized clinical quality, patient experience and operational efficiency. The executive team continues to pursue growth through targeted acquisitions, strategic alliances and the integration of new care models, with an ongoing commitment to serving the needs of patients, families and referral partners across the continuum of post-acute care.

Key Stats

• Today's Range: $12.50 to $12.85
• 50-Day Range: $11.77 to $14.91
• 52-Week Range: $11.65 to $40.98
• Volume: 489,877 shs
• Average Volume: 857,438 shs
• Market Capitalization: $1.55 billion
• P/E Ratio: 11.82
• Dividend Yield: 2.00%
• Price Target: $19.20
• Consensus Rating: Moderate Buy

Select Medical Stock Analysis - MarketRank™

Select Medical scored higher than 100% of companies evaluated by MarketBeat, and ranked 4th out of 958 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.8 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Select Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.

Upside Potential

Select Medical has a consensus price target of $19.20, representing about 53.3% upside from its current price of $12.53.

Amount of Analyst Coverage

Select Medical has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 5.0 / 5
• Proj. Earnings Growth: 20.51%

Earnings Growth

Earnings for Select Medical are expected to grow by 20.51% in the coming year, from $1.17 to $1.41 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Select Medical is 11.82, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 280.41.

Price to Earnings Ratio vs. Sector

The P/E ratio of Select Medical is 11.82, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 74.52.

Price to Earnings Growth Ratio

Select Medical has a PEG Ratio of 0.52. PEG Ratios below 1 indicate that a company could be undervalued.

Price to Book Value per Share Ratio

Select Medical has a P/B Ratio of 0.82. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.40% of the float of Select Medical has been sold short.

Short Interest Ratio / Days to Cover

Select Medical has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Select Medical has recently decreased by 1.92%, indicating that investor sentiment is improving.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Yield

Select Medical pays a meaningful dividend of 1.95%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Select Medical does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Select Medical is 23.58%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Select Medical will have a dividend payout ratio of 17.73% next year. This indicates that Select Medical will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 4.8 / 5
• Environmental Score: -0.92

Percentage of Shares Shorted

3.40% of the float of Select Medical has been sold short.

Short Interest Ratio / Days to Cover

Select Medical has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Select Medical has recently decreased by 1.92%, indicating that investor sentiment is improving.

News and Social Media

• Score: 2.6 / 5
• News Sentiment: 0.68

News Sentiment

Select Medical has a news sentiment score of 0.68. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.93 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 10 news articles for Select Medical this week, compared to 6 articles on an average week.

Search Interest

Only 2 people have searched for SEM on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.

MarketBeat Follows

3 people have added Select Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Select Medical insiders have not sold or bought any company stock.

Percentage Held by Insiders

11.60% of the stock of Select Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

89.48% of the stock of Select Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

SEM Stock Analysis - Frequently Asked Questions

How have SEM shares performed this year?

Select Medical's stock was trading at $18.85 at the start of the year. Since then, SEM shares have decreased by 33.5% and is now trading at $12.5270.

How were Select Medical's earnings last quarter?

Select Medical Holdings Corporation (NYSE:SEM) released its earnings results on Thursday, July, 31st. The health services provider reported $0.32 EPS for the quarter, beating the consensus estimate of $0.28 by $0.04. Select Medical's quarterly revenue was up 4.5% compared to the same quarter last year.
Read the conference call transcript.

Is Select Medical doing a stock buyback?

Select Medical's Board of Directors authorized a share buyback plan on Thursday, May 1st 2025, which allows the company to repurchase $1,000,000,000 in outstanding shares, according to EventVestor. This means that the company could repurchase up to 42.6% of its shares through open market purchases. Shares buyback plans are typically an indication that the company's board of directors believes its shares are undervalued.

Does Select Medical have any subsidiaries?

Select Medical subsidiaries include these companies: AbsoluteCVO, ACC Capital, Actra Rehabilitation Associates, Advantage Rehabilitation Clinics, Alexandria Sports, Allevant Solutions, Ambulatory Care Solutions, and more.

Who are Select Medical's major shareholders?

Select Medical's top institutional shareholders include State Street Corp (3.43%), Geode Capital Management LLC (2.45%), 8 Knots Management LLC (1.41%) and Hood River Capital Management LLC (1.34%). Insiders that own company stock include Robert A Ortenzio, David S Chernow, Parvinderjit S Khanuja, Robert G Breighner Jr and Marilyn B Tavenner.
View institutional ownership trends.

How do I buy shares of Select Medical?

Shares of SEM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Select Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Select Medical investors own include Humana (HUM), American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), TotalEnergies (TTE) and Southern First Bancshares (SFST).

Company Calendar

• Last Earnings: 7/31/2025
• Record date for 8/28 Dividend: 8/13/2025
• Ex-Dividend for 8/28 Dividend: 8/13/2025
• Dividend Payable: 8/28/2025
• Today: 9/12/2025
• Next Earnings (Estimated): 10/30/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MED - HMO
• Sub-Industry: Health Care Facilities
• Current Symbol: NYSE:SEM
• CIK: 1320414
• Web: www.selectmedicalcorp.com
• Phone: (717) 972-1100
• Fax: 717-972-1042
• Employees: 44,100
• Year Founded: 1996

Price Target and Rating

• Average Price Target for Select Medical: $19.20
• High Price Target: $25.00
• Low Price Target: $14.00
• Potential Upside/Downside: +53.3%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.80
• Research Coverage: 5 Analysts

Profitability

• EPS (Trailing Twelve Months): $1.06
• Trailing P/E Ratio: 11.82
• Forward P/E Ratio: 10.71
• P/E Growth: 0.52
• Net Income: $214.04 million
• Net Margins: 2.37%
• Pretax Margin: 3.42%
• Return on Equity: 8.87%
• Return on Assets: 2.93%

Debt

• Debt-to-Equity Ratio: 0.92
• Current Ratio: 1.15
• Quick Ratio: 1.15

Sales & Book Value

• Annual Sales: $5.19 billion
• Price / Sales: 0.30
• Cash Flow: $2.45 per share
• Price / Cash Flow: 5.12
• Book Value: $15.35 per share
• Price / Book: 0.82

Miscellaneous

• Outstanding Shares: 123,990,000
• Free Float: 109,606,000
• Market Cap: $1.55 billion
• Optionable: Optionable
• Beta: 1.25